TABLE 5.
Seroprevalence of Norovirus Infection in Latin America per Genotype and Age Group
| Genotype | Age Group (yr) | Number of Studies | Sample Size | Seroprevalence Range (%) | References |
|---|---|---|---|---|---|
| Overall | All | 6 | 3550 | 2–87 | A31–A36 |
| GI.1 | 0–5 | 3 | 930 | 71–75 | A31, A32, A35 |
| 6–10 | 1 | 54 | 87 | A31 | |
| 11–20 | 1 | 123 | 70 | A31 | |
| 21–30 | 1 | 116 | 72 | A31 | |
| 30+ | 1 | 127 | 85 | A31 | |
| Total | 4 | 1380 | 2–77 | A31, A32, A33, A35 | |
| GII.3 | 1–4 | 1 | 133 | 34 | A34 |
| 5–14 | 1 | 261 | 56 | A34 | |
| 15+ | 1 | 111 | 81 | A34 | |
| Total | 2 | 2359 | 16–57 | A33, A34 | |
| NS | <2 | 1 | 52 | 58 | A36 |
NS indicates not specified.